#Breaking U.S. FDA approves expanded label for our fourth medicine. Learn more: vrtx.com

It’s our privilege to be honored by the Massachusetts Sickle Cell Association (MASCA) with the Outstanding Corporate Partner Award for our ongoing research in #SCD. Read this article from Amit Sachdev to learn more about our commitment to this community. vrtx.com/stories/we-are…

Getting blood transfusions every 3 weeks is just part of life for these brave sisters. They are living with transfusion-dependent beta thalassemia (TDT), an inherited blood disorder, but they don’t let the disease define who they are. Hear from the girls themselves.

Vertex scientists are motivated by the drive to develop the best treatment possible for every person with cystic fibrosis and share a unified, unwavering belief: It’s not a matter of if we’ll do it. It’s a matter of when and how we’ll do it. VRTX.COM

This #CFAwarenessMonth, our Boston office is lit up blue and yellow in honor of the #CysticFibrosis community who drives us to do all that we can to research and develop potential therapies for people living with CF.

Happy #PrideMonth! We look forward to honoring the accomplishments of the LGBTQ+ community with our Vertex PRIDE employee resource network, which is curating events that increase our understanding, build community, and celebrate diversity.

This year marks the 20th anniversary for @OxfordPride, so it was an honor for our Vertexians to attend for the first time, volunteering to support the LGBTQ+ community around us as they celebrate and campaign for equity and justice in the UK and around the world #OxfordPride2023

Our teams and investigators shared new clinical data on our investigational gene-edited therapy for the treatment of sickle cell disease and beta thalassemia at the European Hematology Association 2023 Annual Congress. Learn more: vrtx.com

We are pleased to announce that our biologics license applications (BLA) for our potential treatment for sickle cell disease (SCD) & beta thalassemia have been accepted by the FDA & our application for SCD has been granted priority review. Learn more: news.vrtx.com/news-releases/…

Understanding the root causes of rare diseases is key to finding potential treatments. We partnered with BBC Storyworks to tell our story in their “Nature’s Building Blocks” series.

“Our patients always inspire us to never give up.” Paul Negulescu, Senior Vice President, Research, reflects on the last two decades of taking on new challenges. Learn more about the journey of our drug discovery process.

Congrats to Jeff Willy on being named a Top 50 LGBTQ+ Leader of Influence by @SDBusiness! Founding member and co-chair of our Vertex PRIDE ERN in San Diego, Jeff champions our inclusive culture and drives external outreach activities to advocate for equality and equity for all.

Our teams shared new clinical data for our investigational cell therapy approach for the potential treatment of type 1 diabetes at the American Diabetes Association - DiabetesPro 83rd Scientific Sessions this week. Learn more: vrtx.com

Meet Roberts Zivtins, Head of the Learning Lab at our Oxford Research Site. What motivates him? Providing opportunities for students from traditionally underrepresented backgrounds to meet scientists, learn scientific techniques, and genuinely enjoy science, like we do.

Equipping the next generation one laptop at a time! Read about how our employees are helping to foster learning in their own hometowns. vrtx.com/stories/suppor…

Congrats to our CEO & President Reshma Kewalramani on receiving the Alan E. Lewis Alnoba CEO Social Leadership Award! Fostering scientific breakthroughs, leading courageously and nurturing the next generation of scientists are just a few ways Reshma creates positive impact.

It’s an honor to be named a 2023 Boston Business Journal Top Charitable Contributor. We consider it a privilege to be able to support communities across Massachusetts. Learn more about our commitment by visiting the responsibility section on vrtx.com.

Exploration and innovation — take a peek inside our Learning Labs as high school students are exposed to the power of #STEM.

We’re excited to be ranked #7 on the Science Magazine 2023 Top Employer list! Thank you to our team & industry peers for acknowledging us — making this our 14th consecutive year on this list. Interested in starting or growing your career with us? Visit: vrtx.com/careers/

We’re honored to be led by remarkable women at Vertex! Thank you to The Women's Edge and Globe Magazine for recognizing CEO Reshma Kewalramani’s leadership and business impact, ranking Vertex #1 on the 2023 list of Top 100 Women-Led Businesses in Massachusetts. Learn more: